Alidornase alfaAlternative Names: AIR DNAse™; PRX 110
Latest Information Update: 08 Feb 2017
At a glance
- Originator Protalix BioTherapeutics
- Class Recombinant proteins
- Mechanism of Action Deoxyribonuclease 1 stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Cystic fibrosis